CDC’s independent Advisory Committee on Immunization Practices (ACIP) recommended that people with moderately to severely compromised immune systems receive an additional dose of mRNA COVID-19 vaccine following their initial 2-dose vaccination series. CDC Director Dr. Rochelle Walensky accepted those recommendations, and released a statement.
Below is a list of resources related to the recommendation:
- Updated Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States
Widespread vaccination is a critical tool to help stop this pandemic. At a time when the Delta variant is surging, an additional dose could help prevent serious and possibly life-threatening COVID-19 cases within this population. It’s important to note that CDC does not recommend additional doses or booster shots for any other population at this time. Vaccine providers should administer vaccine in accordance with the updated EUAs per the COVID-19 vaccine provider agreement.
It’s important to note that individuals can self-attest and receive the additional dose wherever vaccines are offered. This will help ensure there are not additional barriers to access for this vulnerable population receiving a needed additional dose. CDC will be providing further information regarding vaccine administration to immunocompromised individuals to states, pharmacies, health centers, and all vaccine providers.